Products for Research Use Only
RegisterLogin

Daratumumab (anti-CD38)

CAT: 0957-A2027-1mg*25Size: 25x 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-A2027-1mg*25Size:25x 1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
945721-28-8
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Related Products

CatalogName
A2819-01Mezagitamab (Anti-CD38)
A2039-1mg*25Isatuximab (anti-CD38)
A2819-1mg*25Mezagitamab (Anti-CD38)
A2819-1mg*5Mezagitamab (Anti-CD38)
A2818-1mg*25Felzartamab (Anti-CD38)
A2818-1mg*5Felzartamab (Anti-CD38)
A2818-1mgFelzartamab (Anti-CD38)
A2039-1mgIsatuximab (anti-CD38)
A2818-01Felzartamab (Anti-CD38)
A2819-1mgMezagitamab (Anti-CD38)

Alternative Products

CatalogName
C00026-1mgDaratumumab (anti-CD38)
GTR18605827-01Anti-CD38 [Daratumumab]
MBS4751616-01Anti-CD38 [Daratumumab] Humanized
F1370-1Anti-CD38 Antibody (Daratumumab)
12-9064-50Anti-CD38 Antibody (daratumumab biosimilar) (HuMax-CD38)
MBS9466662-01Anti-CD38 (daratumumab biosimilar) mAb
E24CHA024Anti-CD38 Reference Antibody (daratumumab)
BIO0010SM-1mgAnti-human CD38 (Daratumumab Biosimilar)
591780-01CD38, Daratumumab Biosimilar
B132501-01V6 Anti-Human CD38 (Daratumumab)

Popular Products